Flagship VentureLabs IV, LLC

Related Filers (20)

Ownership (24)

SC 13G/A
Tuesday, 2/14/2023
Rubius Therapeutics, Inc.: Major Shareholders
SC 13D/A
Monday, 10/17/2022
Axcella Health Inc.: Major Shareholders
SC 13D/A
Friday, 9/23/2022
Axcella Health Inc.: Major Shareholders
SC 13D/A
Thursday, 7/7/2022
Seres Therapeutics, Inc.: Major Shareholders
SC 13D/A
Friday, 3/18/2022
Axcella Health Inc.: Major Shareholders
SC 13D/A
Wednesday, 11/25/2020
Seres Therapeutics, Inc.: Major Shareholders
SC 13D
Wednesday, 5/20/2020
Axcella Health Inc.: Major Shareholders
SC 13D
Friday, 6/28/2019
Seres Therapeutics, Inc.: Major Shareholders
SC 13D
Thursday, 5/23/2019
Axcella Health Inc.: Major Shareholders
4
Wednesday, 5/15/2019
Axcella Health Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 5/8/2019
Axcella Health Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 3/6/2019
Kaleido Biosciences, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 2/27/2019
Kaleido Biosciences, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 12/13/2018
Moderna, Inc.: Statement of changes in beneficial ownership of securities
3
Friday, 12/7/2018
Moderna, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 7/23/2018
Rubius Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 7/17/2018
Rubius Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 5/15/2018
Evelo Biosciences, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 5/8/2018
Evelo Biosciences, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 8/21/2017
Syros Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/7/2016
Syros Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/29/2016
Syros Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 5/27/2016
Seres Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 6/25/2015
Seres Therapeutics, Inc.: Initial statement of beneficial ownership of securities
Show More